AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.
J Infect Dis
; 211(5): 801-10, 2015 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-25293368
Full text:
1
Database:
MEDLINE
Main subject:
Polysorbates
/
Squalene
/
Influenza Vaccines
/
Adjuvants, Immunologic
/
Alpha-Tocopherol
/
Influenza, Human
/
Influenza A Virus, H5N1 Subtype
Type of study:
Clinical_trials
/
Prognostic_studies
Language:
En
Journal:
J Infect Dis
Year:
2015
Type:
Article
Affiliation country:
Thailand